Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02222818 · ClinicalTrials.gov registry record · NA
Cardiac Resynchronization Therapy Efficacy Enhancements
A NA study of Atrial Fibrillation, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
- 19
- Study locations
NCT02222818: Completed NA study of Atrial Fibrillation, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
NCT02222818 is a NA study of Atrial Fibrillation that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 71 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower). The trial reports 19 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02222818, a NA study of Atrial Fibrillation, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
- 19
- Study locations
Study Summary
The purpose of this study is to demonstrate that the amount of effective CRT (Cardiac Resynchronization Therapy) pacing during AF (atrial fibrillation) when CAFRPlus (Conducted AF Response Plus) is applied is not inferior to the amount of effective CRT pacing during AF when CAFR (Conducted AF Response) is applied.
Primary Outcome
The primary objective is to demonstrate that the percent effective CRT pacing during AF when CAFRPlus is applied is not inferior to when CAFR is applied (non-inferiority test).
Conditions Studied
Interventions
- DEVICE Conducted AF Response (CAFR)
- DEVICE Conducted AF Response Plus (CAFRPlus)
Study Locations (19)
Other
- Magyar Honvédség Honvédkorház - Budapest
- Policlinico Universitario Agostino Gemelli - Roma
- Azienda Ospedaliera Bolognini Seriate - Ospedale Bolognini - Seriate
- Azienda Ospedaliera Cardinale Panico - Tricase
- Prince Sultan Cardiac Center - Riyadh
- Vychodoslovensky ustav srdcovych a cievnych chorob, a.s. - Košice
- Mediclinic Panorama - Cape Town
- Liverpool Heart and Chest Hospital NHS Foundation Trust - Liverpool
- he Newcastle upon Tyne Hospitals NHS Foundation Trust - Freeman Hospital - Newcastle upon Tyne
Minnesota
- North Memorial Heart and Vascular - Minneapolis
- CentraCare - Saint Cloud
Florida
- Cardiac Arrythmia Services - Boca Raton
Iowa
- Iowa Heart Center - West Des Moines
North Carolina
- North Carolina Heart and Vascular - Raleigh
Ohio
- Mount Carmel - Columbus
Oklahoma
- Oklahoma Heart - Oklahoma City
Pennsylvania
- Berks Cardiology - Reading
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-01 |
| Phase | NA |
What the finished NCT02222818 record still lists
NCT02222818 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Conducted AF Response (CAFR) is the first listed.
NCT02222818 lists 19 locations in 10 states (Other, Minnesota, Florida).
Frequently Asked Questions
What is clinical trial NCT02222818 about?
NCT02222818 is a clinical study titled "Cardiac Resynchronization Therapy Efficacy Enhancements". The purpose of this study is to demonstrate that the amount of effective CRT (Cardiac Resynchronization Therapy) pacing during AF (atrial fibrillation) when CAFRPlus (Conducted AF Response Plus) is applied is not inferior to the amount of effective CRT pacing during AF when CAFR (Conducted AF Respon...
What is the current status of trial NCT02222818?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2014-10. Estimated completion is 2016-01.
What conditions does trial NCT02222818 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
What interventions are being tested in trial NCT02222818?
The interventions under investigation include: Conducted AF Response (CAFR) (DEVICE), Conducted AF Response Plus (CAFRPlus) (DEVICE).
Who is sponsoring clinical trial NCT02222818?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02222818 being conducted?
This trial has 19 study locations across Florida, Iowa, Minnesota, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02222818's enrollment target sits among peer trials
71 159th of 202 higher than 44 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia